Skip to main content

Table 1 Patient Characteristics

From: Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity

  N.A Adjuvant p
N P Stage IIIa 30 21  
Age Mean 59.83 60.10 0.939
Male N 18 17 0.220
% 51.43 48.57  
FEV1(%) Mean 69.39 72.88 0.644
Laterality of procedure
 Right   13 14 0.154
 Left   17 7
Histological type
 Adenocarcinoma   35.5 28.6  
 Squamous cell carcinoma   48.4 28.6  
 Metastatic thymoma   6.5   
 Large cell carcinoma   9.6 9.5  
 Malignant mesothelioma    28.6  
 Bronchiolo-alveolar carcinoma    4.7